Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rose Geranium in Sesame Oil Nasal Spray as an Agent to Improve Symptoms of Nasal Vestibulitis: A Phase III Double Blinded Randomized Controlled Trial

NCT04620369 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT04620369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04620369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rose Geranium in Sesame Oil Nasal Spray as an Agent to Improve Symptoms of Nasal Vestibulitis: A Phase III Double Blinded Randomized Controlled Trial
Lead sponsor
Mayo Clinic
Phase
Phase 3
Overall status
Completed
Start date
November 13, 2020
Completion date
December 15, 2022
Enrollment
106 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

hematopoietic and lymphoid cell neoplasm, malignant solid neoplasm, nasal vestibulitis